Neurosense Therapeutics Ltd (NRSN) Up 5.76% in Premarket Trading

Neurosense Therapeutics Ltd (NRSN) is up Tuesday morning, with the stock adding 5.76% in pre-market trading to 1.47. NRSN's short-term technical score of 45 indicates that the stock has traded less bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, the stock ranks higher than 60% of stocks. Neurosense Therapeutics Ltd has risen 36.27% over the past month, closing at $1.08 on January 30. During this period of time, the stock fell as low as $1.08 and as high as $1.40. NRSN has an average analyst recommendation of Strong Buy. The company has an average price target of $5.25.

NRSN has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on NRSN!

See Full NRSN Report

Neurosense Therapeutics Ltd has a Long-Term Technical rank of 76. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 24% of the market scoring higher. In the Biotechnology industry which is number 58 by this metric, NRSN ranks better than 58% of stocks.

Important Dates for Investors in NRSN:

-Neurosense Therapeutics Ltd is set to release earnings on 2024-03-27. Over the last 12 months, the company has reported EPS of $-0.94. -We do not have a set dividend date for Neurosense Therapeutics Ltd at this time. Click Here To Get The Full Report on Neurosense Therapeutics Ltd (NRSN)